Analysis of 2-Arachidonoylglycerol Levels in Polycystic Ovary Syndrome in the Context of Hormonal and Metabolic Alterations and Across the Classical Phenotypes.

Kabakchieva, Plamena; Gateva, Antoaneta; Hristova, Julieta; Georgiev, Tsvetoslav; Kamenov, Zdravko

Kabakchieva, Plamena; Gateva, Antoaneta; Hristova, Julieta; Georgiev, Tsvetoslav; Kamenov, Zdravko.

Afiliação

Kabakchieva P; Clinic of Endocrinology, University Hospital "Alexandrovska", Department of Internal Medicine, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria.
Gateva A; Clinic of Internal Diseases, Naval Hospital-Varna, Military Medical Academy, Bulgaria.
Hristova J; Clinic of Endocrinology, University Hospital "Alexandrovska", Department of Internal Medicine, Medical Faculty, Medical University-Sofia, Sofia, Bulgaria.
Georgiev T; Clinical Laboratory and Clinical Pharmacology, University Hospital "Alexandrovska", Department of Clinical Laboratory, Medical University-Sofia, Sofia, Bulgaria.
Kamenov Z; Clinic of Rheumatology, University Hospital "St. Marina", First Department of Internal Medicine, Medical Faculty, Medical University-Varna, Varna, Bulgaria.

Cannabis Cannabinoid Res ; 8(4): 634-641, 2023 08.

Article em En | MEDLINE | ID: mdl-35235418

Assuntos

Síndrome do Ovário Policístico; Humanos; Feminino; Síndrome do Ovário Policístico/metabolismo; Endocanabinoides; Fenótipo

Palavras-chave

2-arachidonoylglycerol; endocannabinoids; female reproductive system; polycystic ovary syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome do Ovário Policístico Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google